Topical psoriasis therapy

Daniel G. Federman; Catherine W. Froelich; Robert S. Kirsner

Topical psoriasis therapy

Daniel G. Federman, Catherine W. Froelich, Robert S. Kirsner

Dermatology & Cutaneous Surgery

Research output: Contribution to journal › Article

21 Scopus citations

Abstract

Psoriasis is a common dermatosis, affecting from 1 to 3 percent of the population. Until recently, the mainstays of topical therapy have been corticosteroids, tars, anthralins and keratolytics. Recently, however, vitamin D analogs, a new anthralin preparation and topical retinoids have expanded physicians' therapeutic armamentarium. These new topical therapies offer increased hope and convenience to the large patient population with psoriasis.

Original language	English (US)
Pages (from-to)	957-962
Number of pages	6
Journal	American Family Physician
Volume	59
Issue number	4
State	Published - Feb 15 1999

ASJC Scopus subject areas

Family Practice

Access to Document

Fingerprint Dive into the research topics of 'Topical psoriasis therapy'. Together they form a unique fingerprint.

Cite this

Federman, D. G., Froelich, C. W., & Kirsner, R. S. (1999). Topical psoriasis therapy. American Family Physician, 59(4), 957-962.

@article{0106736e33ba4960a712577c0c9d6469,

title = "Topical psoriasis therapy",

abstract = "Psoriasis is a common dermatosis, affecting from 1 to 3 percent of the population. Until recently, the mainstays of topical therapy have been corticosteroids, tars, anthralins and keratolytics. Recently, however, vitamin D analogs, a new anthralin preparation and topical retinoids have expanded physicians' therapeutic armamentarium. These new topical therapies offer increased hope and convenience to the large patient population with psoriasis.",

author = "Federman, {Daniel G.} and Froelich, {Catherine W.} and Kirsner, {Robert S.}",

year = "1999",

month = feb,

day = "15",

language = "English (US)",

volume = "59",

pages = "957--962",

journal = "American Family Physician",

issn = "0002-838X",

publisher = "American Academy of Family Physicians",

number = "4",

}

TY - JOUR

T1 - Topical psoriasis therapy

AU - Federman, Daniel G.

AU - Froelich, Catherine W.

AU - Kirsner, Robert S.

PY - 1999/2/15

Y1 - 1999/2/15

N2 - Psoriasis is a common dermatosis, affecting from 1 to 3 percent of the population. Until recently, the mainstays of topical therapy have been corticosteroids, tars, anthralins and keratolytics. Recently, however, vitamin D analogs, a new anthralin preparation and topical retinoids have expanded physicians' therapeutic armamentarium. These new topical therapies offer increased hope and convenience to the large patient population with psoriasis.

AB - Psoriasis is a common dermatosis, affecting from 1 to 3 percent of the population. Until recently, the mainstays of topical therapy have been corticosteroids, tars, anthralins and keratolytics. Recently, however, vitamin D analogs, a new anthralin preparation and topical retinoids have expanded physicians' therapeutic armamentarium. These new topical therapies offer increased hope and convenience to the large patient population with psoriasis.

UR - http://www.scopus.com/inward/record.url?scp=0033558254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033558254&partnerID=8YFLogxK

M3 - Article

C2 - 10068717

AN - SCOPUS:0033558254

VL - 59

SP - 957

EP - 962

JO - American Family Physician

JF - American Family Physician

SN - 0002-838X

IS - 4

ER -